Recent advances in xenotransplantation

Current Opinion in Immunology

Volumn 11, Issue 5, 1999, Pages 527-531

  Sandrin, Mauro S ^a   McKenzie, Ian Fc ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT;

COMPLEMENT ACTIVATION; GRAFT REJECTION; HOST RESISTANCE; HUMAN; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; REVIEW; SWINE; XENOTRANSPLANTATION;

EID: 0032826690     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00011-4     Document Type: Review

References (45)

1. Sandrin MS, Vaughan HA, McKenzie IFC Identification of Galα(1,3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplant Rev. 8:1994;134-149.
2. Sandrin MS, McKenzie IFC Galα(1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev. 141:1994;169-190.
3. Cooper DK, Koren E, Oriol R Oligosaccharides and discordant xenotransplantation. Immunol Rev. 141:1994;31-58.
4. Cozzi E, White DJG The generation of transgenic pigs as potential organ donors for humans. Nat Med. 1:1995;964-966.
5. Pearse MJ, Cowan P, van Dendren BJ, d'Apice A The role of complement activation in xenograft rejection. Curr Opin Organ Transplant. 2:1997;103-108.
6. Ryan US Complement inhibitory therapeutics and xenotransplantation. Nat Med. 1:1995;967-968.
7. Osman N, McKenzie IFC, Ostenreid K, Ioannou YA, Desnick RJ, Sandrin MS Combined transgenic expression of α-galactosidase and α1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galα(1,3)Gal. Proc Natl Acad Sci USA. 94:1997;14677-14682.
8. Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohney S, Rollins SA, Guilmette ER, Setter E, Squinto SP, McKenzie IFC Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med. 1:1995;1261-1267.
9. Cohney S, McKenzie IFC, Patton K, Prenzoska J, Ostenreid K, Fodor WL, Sandrin MS Down-regulation of Gal α(1,3)Gal expression by α1,2-fucosyltransferase: further characterization of α1,2-fucosyltransferase transgenic mice. Transplantation. 64:1997;495-500.
10. Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL, Logan JS Reduction in the level of Gal(α1,3)Gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA. 93:1996;7190-7195.
11. Tanemura M, Miyagawa S, Koyota S, Koma M, Matsuda H, Tsuji S, Shirakura R, Taniguchi N Reduction of the major swine xenoantigen, the α-galactosyl epitope by transfection of the α2,3-sialyltransferase gene. J Biol Chem. 273:1998;16421-16425.
12. Tanemura M, Miyagawa S, Ihara Y, Matsuda H, Shirakura R, Taniguchi N Significant downregulation of the major swine xenoantigen by N-acetylglucosaminyltransferase III gene transfection. Biochem Biophys Res Commun. 235:1998;359-364.
13. Vanhove B, Charreau B, Cassard A, Pourcel C, Soulillou JP Intracellular expression in pig cells of anti-α1,3galactosyl-transferase single-chain FV antibodies reduces Gal α1,3Gal expression and inhibits cytotoxicity mediated by anti-Gal xenoantibodies. Transplantation. 66:1998;1477-1485. This paper demonstrates an alternative and novel approach to decrease the level of Galα(1,3)Gal expression, by targeting the enzyme with an antibody.
14. Hinchliffe SJ, Rushmere NK, Hanna SM, Morgan BP Molecular cloning and functional characterization of the pig analogue of CD59: relevance to xenotransplantation. J Immunol. 160:1998;3924-3932. This paper shows that it is the level of expression of a complement regulator that may be as important as the species from which that regulator is derived.
15. Thall AD, Maly P, Lowe JB Oocyte Galα(1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem. 270:1995;21437-21440.
16. Tearle RG, Tange MJ, Zannettino ZL, Katerelos M, Shinkel TA, Van Denderen BJW, Lonie AJ, Lyons I, Nottle MB, Cox Tet al. The a-1,3-galactosyltransferase knockout mouse: implications for xenotransplantation. Transplantation. 61:1995;13-19.
17. •] describe the use of Gal o/o mice as small-animal models for the investigation of the destruction of transplanted organs that is mediated by anti-Galα(1,3)Gal antibodies.
18. •].
19. Lambrigts D, Sachs DH, Cooper DKC Discordant organ xenotransplantation in primates: world experience and current status. Transplantation. 66:1998;547-561. An excellent review on the current status of pig-to-primate transplant trials.
20. Ierino FL, Kozlowski T, Siegel JB, Shimizu A, Colvin RB, Banerjee PT, Cooper DKC, Cosimi AB, Bach FH, Sachs DH, Robson SC Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation. 66:1998;1439-1450.
21. McKenzie IFC, Koulmanda M, Mandell TE, Sandrin MS Pig islet xenografts are susceptible to 'anti-pig' but not Gal alpha(1,3)Gal antibody plus complement in Gal o/o mice. J Immunol. 161:1998;5116-5119. This paper shows that pancreatic islet cells are resistant to anti-Galα(1,3)Gal-mediated hyperacute rejection.
22. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom C, Andersson A Transplantation of porcine fetal pancreas to diabetic patients. Lancet. 344:1994;1402-1404.
23. Soderlund J, Wennberg L, Castanos-Velez E, Biberfeld P, Zhu S, Tibell A, Groth CG, Korsgren O Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation. 67:1999;784-791.
24. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC Delayed xenograft rejection. Immunol Today. 17:1996;379-384.
25. Inverardi L, Clissi B, Stolzer AL, Bender JR, Sandrin MS, Pardi R Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation. 63:1997;1318-1330.
26. Artrip JH, Kwiatkowski P, Wang S-F, Tugulea S, Ankersmit J, Chisholm L, Michler RE, McKenzie IFC, Sandrin MS, Itescu S Target cell susceptibility to lysis by human natural killer cells is augmented by α(1,3)-galactosyltransferase and reduced by α(1,2)-fucosyltransferase. J Biol Chem. 274:1999;10717-10722. This paper not only confirms and extends the observation of human NK cell recognition of Galα(1,3)Gal but also demonstrates that the approach used to decrease the binding of anti-Galα(1,3)Gal antibody to cells [8] also decreases NK cell recognition.
27. Millan MT, Geczy C, Stuhlmeier KM, Goodman DJ, Ferran C, Bach FH Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor type-1 expression. Transplantation. 63:1997;421-429.
28. Kwiatkowski P, Artrip JH, Edwards NM, Lietz K, Tugulea S, Michler RE, McKenzie IFC, Sandrin MS, Itescu S High level porcine endothelial cell expression of α(1,2)-fucosyltransferase reduces human monocyte adhesion and activation. Transplantation. 67:1999;219-226. This paper demonstrates that the approach used to decrease binding of anti-Galα(1,3)Gal antibody to cells [8] also decreases human monocyte adhesion to pig cells and subsequent monocyte activation.
29. Yi S, Feng X, Wang Y, Kay TW, Wang Y, O'Connell PJ CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway. Transplantation. 67:1999;435-443.
30. Fujiwara I, Nakajima H, Yamagishi H, Matsuda T, Mizuta N, Oka T The molecular mechanism of apoptosis induced by xenogeneic cytotoxicity. Xenotransplantation. 5:1998;50-56.
31. Yang Y-G, deGoma E, Ohdan H, Bracy JL, Xu Y, Iacomini J, Thall AD, Sykes M Tolerization of anti-Galα1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med. 187:1998;1335-1342. This paper and [32,33] report that it is possible to tolerize B cells that produce anti-Galα(1,3)Gal antibody by bone marrow grafts.
32. Bracy JL, Sachs DH, Iacomini J Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science. 281:1998;1845-1847.
33. Kozlowski T, Monroy R, Xu Y, Glaser R, Awwad M, Cooper DKC, Sachs DH Anti-Gal(alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction. Transplantation. 66:1998;176-182.
34. Kozlowski T, Shimizu A, Lambrigts D, Yamada K, Fuchimoto Y, Glaser R, Monroy R, Xu Y, Awwad M, Colvin RBet al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation. 67:1999;18-30.
35. Deck B, Elofsson M, Kihlberg J, Unanue ER Specificity of glycopeptide-specific T cells. J Immunol. 155:1995;1074-1078.
36. Harding CV, Kihlberg J, Elofsson M, Magnusson G, Unanue ER Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol. 151:1993;2419-2425.
37. Haurum JS, Arsequell G, Lellouch AC, Wong SYC, Dwek RA, McMichael AJ, Elliot T Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. J Exp Med. 180:1994;739-744.
38. Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S, Reinhold VN, Sieling PA, Modlin RLet al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 278:1997;283-286.
39. Spada FM, Koezuka Y, Porcelli SA CD1d-restricted recognition of synthetic glycolipid antigen by human natural killer T cells. J Exp Med. 188:1998;1529-1534.
40. Brossay L, Chioda M, Burdin N, Koezuka Y, Casarati G, Dellabona P, Kronrnberg M CD1d-mediated recognition of an α-galactosyl-ceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 188:1998;1521-1528.
41. Brossay L, Naidenko O, Matsuda J, Sakai T, Kronenberg M Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J Immunol. 161:1998;5124-5128.
42. Patience C, Takeuchi Y, Weiss A Infection of human cells by endogenous retrovirus of pigs. Nat Med. 3:1997;282-286.
43. Martin U, Klessig V, Blusch JH Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet. 352:1998;692-694.
44. Heneine W, Tibell A, Switzer WM No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet. 352:1998;695-699.
45. Patience C, Patton GS, Takeuchi Y No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet. 352:1998;699-701.